Adjustment of sufentanyl dose according to maternal cervical dilatation in labor analgesia

Adjustment of sufentanyl dose according to maternal cervical dilatation in intermittent epidural infusion of labor analgesia.

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR1900021683

Enrollment

Unknown

Registered

2019-03-05

Start date

2019-04-01

Completion date

Unknown

Last updated

2019-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Labor analgesia

Interventions

Experimental group:Adjustment of sufentanyl

Control group:PCEA

Eligibility

Sex/Gender

Female

Age

20 Years to 40 Years

Inclusion criteria

Inclusion criteria: Maternals aged 20-40 years, ASA 2, with singleton, cephalic, term (>37-weeks gestation) pregnancy, and cervical dilitation of 2-4cm, required labor analgesia will be selected and randomly allocated into two groups.

Exclusion criteria

Exclusion criteria: Contraindication for epidural anesthesia (coagulation disorders, infection of the involved site, lumbar disk protrusion and rachiterata), allergy to the drugs, extreme obesity (BMI?32) and other severe medical diseases.

Design outcomes

Primary

Measure	Time frame
consumption of sufentanyl;VAS scores;sensory level of analgesia;	—

Secondary

Measure	Time frame
pruritus;time of labor stages;	—

Countries

China

Contacts

Public ContactYing Sheng

the International Peace Maternity and Child Health Hospital-Shanghai JiaoTong University School of Medicine, Shanghai, China

woaiwojia217918@163.com18017316131

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026